BRAF and thyroid nodule: As reported in the previous studies, 10% to 40% of all US-guided FNAB samples yield indeterminate cytological findings20,21 and BRAF mutation analysis shows relatively low sensitivity for the diagnosis of PTC.35 Our prediction models clarify the probability of PTC in thyroid nodules with indeterminate FNAB and complement the low sensitivity of BRAF mutation analysis.